796 



INDEX 



Starch fermentation by Pneumococ- 



cus, 67 

 Sterility tests on final containers of 

 antipneumococcic serum, 591, 662- 

 663 

 Streptococcus 



action on inulin, 69 

 in lobar pneumonia, 217 

 relation to Pneumococcus, 175 

 transmutation of species, 169-177 

 Streptococcus haemolyticus 

 dissociation, 106 

 peroxide formation, 75, 76 

 variants, 166 

 Streptococcus lanceolatus, 427 

 Streptococcus lanceolatus Pasteuri, 1, 



17, 388 

 Streptococcus mucosus 

 action on inulin, 68 

 bile solubility, 56, 57 

 peroxide formation, 76 

 reclassification, 110, 361-362 

 relation to Type III Pneumococcus, 



110 

 stain for, 32 

 Streptococcus viridans, 75 

 Subarachnoid fluid, Pneumococcus 



in, 2, 6, 16 

 Sucrose fermentation by Pneumococ- 

 cus, 67 

 Sugars 

 effect on growth of Pneumococcus, 



39 

 function in determining antigenic- 

 ity, 253-265 

 See also Carbohydrate fermentation 

 by Pneumococcus ; Carbohydrate 

 fractions; Conjugated carbohy- 

 drate-proteins 

 Sulfur in polysaccharides, 271, 287 

 Susceptibility of animal host to Pneu- 

 mococcus. See Animals, experi- 

 mental 

 Swine serum 



agglutinins in, 431, 432 

 anti-R bodies in, 155 

 Synergism with antipneumococcic se- 



Synergism with antipneumococcic se- 

 rum (cont.): 



cinchona derivatives, ethylhydrocu- 

 preine and optochin base, 518 



gold, 510 



sodium oleate, 518 



Test(s). See Agglutination; Bacteri- 

 cidal tests; Identity test for anti- 

 pneumococcic serum ; Potency 

 tests for antipneumococcic serum; 

 Precipitation ; Preservatives for 

 antipneumococcic serum, tests 

 for; Protection tests; Safety 

 tests; Therapeutic tests; Type 

 determination 

 Tetanus, hemotoxin, 86 

 Therapeutic serum, production, 543- 



565 

 Therapeutic tests for antipneumo- 

 coccic serum, 576-580 

 Therapy. See Serum treatment of 

 lobar pneumonia; Vaccine ther- 

 apy 

 Thermal death-point of Pneumococ- 

 cus, 51 

 Tissue extracts 



as antigens, 337-338 

 in therapy, 23 

 Total solids, determination in anti- 

 pneumococcic serum, 589 

 Toxin(s), 21, 27, 93-101 



adjuvant action on virulence, 98 

 anaerobic, 99 



anaphylactic symptoms, 94, 95 

 in guinea pigs, 95 

 in rabbits, 96 

 antigenicity, 93, 95, 338-340 

 antitoxins. See Antitoxin (s) 

 effect on mice, 97, 99 

 endotoxin, 97 

 exotoxin, 97 



in autolysates, 94, 97, 98 

 in filtrates, 97, 98 

 in lung exudates, 96 

 in skin tests, 97, 99, 461, 467, 468 

 in sodium ricinoleate solutions of 

 Pneumococcus, 96 



